Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey

Showing results (91-100 of 651) with videos related to

Pageof 66
Sort By:
Occupational Medicine (Oxford, England)|September 4, 1999
Small bakeries--a cross-sectional study of respiratory symptoms, sensitization and dust exposureP Jeffrey, P Griffin, M Gibson, et al.
Gastroenterology|March 1, 1996
Molecular regulation of transferrin receptor and ferritin expression in the rat gastrointestinal tractG P Jeffrey, K A Basclain, T L Allen
CNS & Neurological Disorders Drug Targets|August 26, 2009
Glutamate receptors as therapeutic targets for Parkinson's diseaseKari A Johnson, P Jeffrey Conn, Colleen M Niswender
Molecular Biosystems|June 29, 2010
Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disordersGregory J Digby, Jana K Shirey, P Jeffrey Conn
American Journal of Hospital Pharmacy|November 1, 1982
Career goals and expectations of men and women pharmacy residentsC M King, E J Oliver, L P Jeffrey
Journal of Gastroenterology and Hepatology|November 1, 1990
Primary biliary cirrhosis: clinicopathological characteristics and outcomeG P Jeffrey, W D Reed, K B Shilkin
Journal of Chemical Theory and Computation|December 5, 2015
Revised Basis Sets for the LANL Effective Core PotentialsLindsay E Roy, P Jeffrey Hay, Richard L Martin
Behavioural Brain Research|March 1, 2021
Targeting muscarinic receptors to treat schizophreniaDaniel J Foster, Zoey K Bryant, P Jeffrey Conn
Current Topics in Medicinal Chemistry|September 24, 2005
New therapeutic frontiers for metabotropic glutamate receptorsColleen M Niswender, Carrie K Jones, P Jeffrey Conn
Discovery Medicine|December 4, 2012
Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signalingMeredith J Noetzel, Carrie K Jones, P Jeffrey Conn
Pageof 66

Showing results (91-100 of 651) with videos related to

Sort By:
Pageof 66
Occupational Medicine (Oxford, England)|September 4, 1999
Small bakeries--a cross-sectional study of respiratory symptoms, sensitization and dust exposureP Jeffrey, P Griffin, M Gibson, et al.
Gastroenterology|March 1, 1996
Molecular regulation of transferrin receptor and ferritin expression in the rat gastrointestinal tractG P Jeffrey, K A Basclain, T L Allen
CNS & Neurological Disorders Drug Targets|August 26, 2009
Glutamate receptors as therapeutic targets for Parkinson's diseaseKari A Johnson, P Jeffrey Conn, Colleen M Niswender
Molecular Biosystems|June 29, 2010
Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disordersGregory J Digby, Jana K Shirey, P Jeffrey Conn
American Journal of Hospital Pharmacy|November 1, 1982
Career goals and expectations of men and women pharmacy residentsC M King, E J Oliver, L P Jeffrey
Journal of Gastroenterology and Hepatology|November 1, 1990
Primary biliary cirrhosis: clinicopathological characteristics and outcomeG P Jeffrey, W D Reed, K B Shilkin
Journal of Chemical Theory and Computation|December 5, 2015
Revised Basis Sets for the LANL Effective Core PotentialsLindsay E Roy, P Jeffrey Hay, Richard L Martin
Behavioural Brain Research|March 1, 2021
Targeting muscarinic receptors to treat schizophreniaDaniel J Foster, Zoey K Bryant, P Jeffrey Conn
Current Topics in Medicinal Chemistry|September 24, 2005
New therapeutic frontiers for metabotropic glutamate receptorsColleen M Niswender, Carrie K Jones, P Jeffrey Conn
Discovery Medicine|December 4, 2012
Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signalingMeredith J Noetzel, Carrie K Jones, P Jeffrey Conn
Pageof 66